Ibogaine and Methadone Patient Advocates: An Early History

Table of Contents

3) Lotsof HS to Dole VP, personal communication, 01.23.03 (redacted)

4) Dole VP to Lotsof HS, personal communication, 02.06.03

5) Dole VP and Nyswander ME, Heroin Addiction – A Metabolic Disease.
Arch Intern Med 120:19-24, 1967.

6) Federal Regulation of Methadone Treatment, Institute of Medicine.
Chapter 5:120-150, National Academic Press, 1995.

7) Joseph H, Medical Methadone Maintenance: The Further Concealment
of a Stigmatized Condition. Doctoral thesis, City University of
New York, 1995.

XI From the Viewpoint of the Practicing Physicians
XII The Patients Speak
References

8) Link BG & Phelen JC, On Stigma and its Public Health Implications.
Columbia University, 2001.

9) Lotsof HS and Alexander NE, Case Studies of Ibogaine Treatment:
Implications for Patient Management Strategies. The Akaloids,
Vol 56:293-313, Academic Press, 2001.

10) Alper KA, A Contemporary History of Ibogaine in the United States and
Europe. The Alkaloids, Vol 56:249-282, Academic Press, 2001.

11) Popik P and Skolnick P, Pharmacology of Ibogaine and
Ibogaine-Related Alkaloids. The Alkaloids, Vol 52:197-231,
Academic Press, 1998.

return to AATOD conference page

The DWF site is a historical archive. With the exception of this message no content has been altered or changed in any manner. Many links will no longer work, most email addresses and phone numbers are outdated (unless you have access to a time machine that connects with the 2000s). For a present-day organization based upon similar concepts (circa 2015) you may want to try visiting GITA.